AbbVie Pre-Tax Income 2010-2025 | ABBV

AbbVie pre-tax income for the twelve months ending March 31, 2025 was $3.622B, a 51.9% decline year-over-year.

  • AbbVie annual pre-tax income for 2024 was $3.716B, a 40.54% decline from 2023.
  • AbbVie annual pre-tax income for 2023 was $6.25B, a 53.62% decline from 2022.
  • AbbVie annual pre-tax income for 2022 was $13.477B, a 3.76% increase from 2021.

AbbVie Pre-Tax Income 2010-2025 | ABBV

  • AbbVie annual pre-tax income for 2024 was $3.716B, a 40.54% decline from 2023.
  • AbbVie annual pre-tax income for 2023 was $6.25B, a 53.62% decline from 2022.
  • AbbVie annual pre-tax income for 2022 was $13.477B, a 3.76% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
Johnson & Johnson (JNJ)$379.5B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Merck (MRK)$196.7B
Sanofi (SNY)$128.6B
Pfizer (PFE)$125.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B